Stanley-Laman Group, Ltd. - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 55 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2015. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
Stanley-Laman Group, Ltd. ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q2 2016$90,000
-15.1%
25,7220.0%0.04%
+75.0%
Q1 2016$106,000
-7.0%
25,7220.0%0.02%0.0%
Q4 2015$114,000
-27.4%
25,7220.0%0.02%
-37.5%
Q3 2015$157,00025,7220.03%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q3 2015
NameSharesValueWeighting ↓
COWEN AND COMPANY, LLC 4,331,020$7,882,0001.31%
RTW INVESTMENTS, LP 6,869,281$12,502,0000.35%
A.R.T. Advisors, LLC 14,140$26,0000.04%
Hudson Bay Capital Management LP 975,000$1,774,0000.03%
Secure Asset Management, LLC 10,000$18,0000.01%
OSAIC HOLDINGS, INC. 1,774,935$3,230,0000.01%
FNY Investment Advisers, LLC 9,900$18,0000.01%
Squarepoint Ops LLC 322,225$586,0000.01%
LMR Partners LLP 107,912$196,0000.01%
Virtu Financial LLC 17,147$31,0000.00%
View complete list of ARBUTUS BIOPHARMA CORP shareholders